96 related articles for article (PubMed ID: 25194533)
1. Investigation of clinicopathological parameters alongside with p53 expression in primary and recurrent keratocysticodontogenic tumours.
Razavi SM; Khalesi S; Torabinia N
Malays J Pathol; 2014 Aug; 36(2):105-13. PubMed ID: 25194533
[TBL] [Abstract][Full Text] [Related]
2. Histopathological features that predict the recurrence of odontogenic keratocysts.
Cottom HE; Bshena FI; Speight PM; Craig GT; Jones AV
J Oral Pathol Med; 2012 May; 41(5):408-14. PubMed ID: 22085015
[TBL] [Abstract][Full Text] [Related]
3. Significance of podoplanin expression in keratocystic odontogenic tumor.
Okamoto E; Kikuchi K; Miyazaki Y; González-Alva P; Oku Y; Tanaka A; Yoshida N; Fujinami M; Ide F; Sakashita H; Kusama K
J Oral Pathol Med; 2010 Jan; 39(1):110-4. PubMed ID: 19925582
[TBL] [Abstract][Full Text] [Related]
4. Characterization and management of the keratocystic odontogenic tumor in relation to its histopathological and biological features.
Mendes RA; Carvalho JF; van der Waal I
Oral Oncol; 2010 Apr; 46(4):219-25. PubMed ID: 20189443
[TBL] [Abstract][Full Text] [Related]
5. Can clinical and radiological features predict recurrence in solitary keratocystic odontogenic tumors?
MacDonald D; Gu Y; Zhang L; Poh C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):263-71. PubMed ID: 23312920
[TBL] [Abstract][Full Text] [Related]
6. Immunolocalization of podoplanin in benign odontogenic tumours with and without ectomesenchyme.
Caetano Ados S; Tjioe KC; Faustino SE; Hanemann JA; Belone Ade F; Soares CT; Oliveira DT
Arch Oral Biol; 2013 Apr; 58(4):408-15. PubMed ID: 22763018
[TBL] [Abstract][Full Text] [Related]
7. miR-15a/16-1 influences BCL2 expression in keratocystic odontogenic tumors.
Diniz MG; Gomes CC; de Castro WH; Guimarães AL; De Paula AM; Amm H; Ren C; MacDougall M; Gomez RS
Cell Oncol (Dordr); 2012 Aug; 35(4):285-91. PubMed ID: 22684875
[TBL] [Abstract][Full Text] [Related]
8. Recurrence of keratocystic odontogenic tumor: clinicopathological features and immunohistochemical study of the Hedgehog signaling pathway.
Yagyuu T; Kirita T; Sasahira T; Moriwaka Y; Yamamoto K; Kuniyasu H
Pathobiology; 2008; 75(3):171-6. PubMed ID: 18550914
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of TLR3 and TLR4 in keratocystic odontogenic tumor (KCOT): A comparative immunohistochemical study in primary, recurrent, and nevoid basal cell carcinoma syndrome (NBCCS)--associated lesions.
Leonardi R; Perrotta RE; Crimi S; Matthews JB; Barbato E; dos Santos JN; Rusu M; Bufo P; Bucci P; Pannone G
J Craniomaxillofac Surg; 2015 Jul; 43(6):733-7. PubMed ID: 25976039
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for keratocystic odontogenic tumor (odontogenic keratocyst): analysis of clinico-pathologic and immunohistochemical findings in cysts treated by enucleation.
Kuroyanagi N; Sakuma H; Miyabe S; Machida J; Kaetsu A; Yokoi M; Maeda H; Warnakulasuriya S; Nagao T; Shimozato K
J Oral Pathol Med; 2009 Apr; 38(4):386-92. PubMed ID: 19141056
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rate of keratocystic odontogenic tumor after conservative surgical treatment without adjunctive therapies - A 35-year single institution experience.
Zecha JA; Mendes RA; Lindeboom VB; van der Waal I
Oral Oncol; 2010 Oct; 46(10):740-2. PubMed ID: 20797899
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of clinical immunohistochemical findings in keratocystic odontogenic tumours and ameloblastomas considering their risk of recurrence].
Driemel O; Rieder J; Morsczeck C; Schwarz S; Hakim SG; Müller-Richter U; Reichert TE; Kosmehl H
Mund Kiefer Gesichtschir; 2007 Sep; 11(4):221-31. PubMed ID: 17641919
[TBL] [Abstract][Full Text] [Related]
13. Beta-catenin and survivin expression in keratocystic odontogenic tumor (KCOT). A comparative immunohistochemical study in primary, recurrent and nevoid basal cell carcinoma syndrome (NBCCS)-associated lesions.
Leonardi R; Matthews JB; Loreto C; Musumeci G; Campisi G; Lo Muzio L; dos Santos JN; Pastorino L; Bufo P; Pannone G
Histol Histopathol; 2013 Sep; 28(9):1175-84. PubMed ID: 23572266
[TBL] [Abstract][Full Text] [Related]
14. Decompression of keratocystic odontogenic tumors leading to increased fibrosis, but without any change in epithelial proliferation.
Awni S; Conn B
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jun; 123(6):634-644. PubMed ID: 28377093
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive keratin profiling reveals different histopathogenesis of keratocystic odontogenic tumor and orthokeratinized odontogenic cyst.
Aragaki T; Michi Y; Katsube K; Uzawa N; Okada N; Akashi T; Amagasa T; Yamaguchi A; Sakamoto K
Hum Pathol; 2010 Dec; 41(12):1718-25. PubMed ID: 20801488
[TBL] [Abstract][Full Text] [Related]
16. Integrated genotypic analysis of hedgehog-related genes identifies subgroups of keratocystic odontogenic tumor with distinct clinicopathological features.
Shimada Y; Katsube K; Kabasawa Y; Morita K; Omura K; Yamaguchi A; Sakamoto K
PLoS One; 2013; 8(8):e70995. PubMed ID: 23951062
[TBL] [Abstract][Full Text] [Related]
17. Perlecan-rich epithelial linings as a background of proliferative potentials of keratocystic odontogenic tumor.
Tsuneki M; Cheng J; Maruyama S; Ida-Yonemochi H; Nakajima M; Saku T
J Oral Pathol Med; 2008 May; 37(5):287-93. PubMed ID: 18205742
[TBL] [Abstract][Full Text] [Related]
18. Syndecan-1 (CD 138) surface expression marks cell type and differentiation in ameloblastoma, keratocystic odontogenic tumor, and dentigerous cyst.
Al-Otaibi O; Khounganian R; Anil S; Rajendran R
J Oral Pathol Med; 2013 Feb; 42(2):186-93. PubMed ID: 22747594
[TBL] [Abstract][Full Text] [Related]
19. A comparative immunohistochemical analysis of COX-2, p53, and Ki-67 expression in keratocystic odontogenic tumors.
Mendes RA; Carvalho JF; van der Waal I
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Mar; 111(3):333-9. PubMed ID: 21215666
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of glucose transporter 1 in keratin-producing odontogenic cysts.
Vera-Sirera B; Forner-Navarro L; Vera-Sempere F
BMC Oral Health; 2016 Mar; 16():32. PubMed ID: 26965170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
